152 related articles for article (PubMed ID: 32070732)
21. Development of new chitosan/carrageenan nanoparticles for drug delivery applications.
Grenha A; Gomes ME; Rodrigues M; Santo VE; Mano JF; Neves NM; Reis RL
J Biomed Mater Res A; 2010 Mar; 92(4):1265-72. PubMed ID: 19322874
[TBL] [Abstract][Full Text] [Related]
22. Anti-proliferate and apoptosis triggering potential of methotrexate-transferrin conjugate encapsulated PLGA nanoparticles with enhanced cellular uptake by high-affinity folate receptors.
Parmar A; Jain A; Uppal S; Mehta SK; Kaur K; Singh B; Sandhir R; Sharma S
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):704-719. PubMed ID: 29745729
[TBL] [Abstract][Full Text] [Related]
23. Nanoparticles based on chitosan hydrochloride/hyaluronic acid/PEG containing curcumin: In vitro evaluation and pharmacokinetics in rats.
Xu Y; Asghar S; Yang L; Chen Z; Li H; Shi W; Li Y; Shi Q; Ping Q; Xiao Y
Int J Biol Macromol; 2017 Sep; 102():1083-1091. PubMed ID: 28472690
[TBL] [Abstract][Full Text] [Related]
24. Development and evaluation of carboplatin-loaded PCL nanoparticles for intranasal delivery.
Alex AT; Joseph A; Shavi G; Rao JV; Udupa N
Drug Deliv; 2016 Sep; 23(7):2144-2153. PubMed ID: 25544603
[TBL] [Abstract][Full Text] [Related]
25. Preparation and Evaluation of N-Trimethyl Chitosan Nanoparticles of Flurbiprofen for Ocular Delivery.
Shinde UA; Joshi PN; Jain DD; Singh K
Curr Eye Res; 2019 May; 44(5):575-582. PubMed ID: 30632402
[TBL] [Abstract][Full Text] [Related]
26. Cromolyn chitosan nanoparticles as a novel protective approach for colorectal cancer.
Motawi TK; El-Maraghy SA; ElMeshad AN; Nady OM; Hammam OA
Chem Biol Interact; 2017 Sep; 275():1-12. PubMed ID: 28732690
[TBL] [Abstract][Full Text] [Related]
27. Physicochemical characterization, in vitro and in vivo evaluation of chitosan/carrageenan encumbered with Imatinib mesylate-polysarcosine nanoparticles for sustained drug release and enhanced colorectal cancer targeted therapy.
Bhattacharya S; Bonde S; Hatware K; Sharma S; Anjum MM; Sahu RK
Int J Biol Macromol; 2023 Aug; 245():125529. PubMed ID: 37379942
[TBL] [Abstract][Full Text] [Related]
28. Tumor micro-environment sensitive release of doxorubicin through chitosan based polymeric nanoparticles: An in-vitro study.
Akram MU; Abbas N; Farman M; Manzoor S; Khan MI; Osman SM; Luque R; Shanableh A
Chemosphere; 2023 Feb; 313():137332. PubMed ID: 36427576
[TBL] [Abstract][Full Text] [Related]
29. Stability, Intracellular Delivery, and Release of siRNA from Chitosan Nanoparticles Using Different Cross-Linkers.
Raja MA; Katas H; Jing Wen T
PLoS One; 2015; 10(6):e0128963. PubMed ID: 26068222
[TBL] [Abstract][Full Text] [Related]
30. Erlotinib loaded chitosan nanoparticles: Formulation, physicochemical characterization and cytotoxic potential.
Pandey P; Dua K; Dureja H
Int J Biol Macromol; 2019 Oct; 139():1304-1316. PubMed ID: 31404602
[TBL] [Abstract][Full Text] [Related]
31. Layer-by-layer polymer coated gold nanoparticles for topical delivery of imatinib mesylate to treat melanoma.
Labala S; Mandapalli PK; Kurumaddali A; Venuganti VV
Mol Pharm; 2015 Mar; 12(3):878-88. PubMed ID: 25587849
[TBL] [Abstract][Full Text] [Related]
32. Modulation of Pharmacokinetic and Cytotoxicity Profile of Imatinib Base by Employing Optimized Nanostructured Lipid Carriers.
Gupta B; Poudel BK; Tran TH; Pradhan R; Cho HJ; Jeong JH; Shin BS; Choi HG; Yong CS; Kim JO
Pharm Res; 2015 Sep; 32(9):2912-27. PubMed ID: 25939551
[TBL] [Abstract][Full Text] [Related]
33. Chitosan based sorafenib tosylate loaded magnetic nanoparticles: Formulation and in-vitro characterization.
Dahiya M; Awasthi R; Yadav JP; Sharma S; Dua K; Dureja H
Int J Biol Macromol; 2023 Jul; 242(Pt 2):124919. PubMed ID: 37196717
[TBL] [Abstract][Full Text] [Related]
34. Fabrication, characterization and bioevaluation of silibinin loaded chitosan nanoparticles.
Pooja D; Babu Bikkina DJ; Kulhari H; Nikhila N; Chinde S; Raghavendra YM; Sreedhar B; Tiwari AK
Int J Biol Macromol; 2014 Aug; 69():267-73. PubMed ID: 24863917
[TBL] [Abstract][Full Text] [Related]
35. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?
Qu J; Zhang L; Chen Z; Mao G; Gao Z; Lai X; Zhu X; Zhu J
Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462
[TBL] [Abstract][Full Text] [Related]
36. Maximizing the Therapeutic Efficacy of Imatinib Mesylate-Loaded Niosomes on Human Colon Adenocarcinoma Using Box-Behnken Design.
Kassem MA; El-Sawy HS; Abd-Allah FI; Abdelghany TM; El-Say KM
J Pharm Sci; 2017 Jan; 106(1):111-122. PubMed ID: 27544432
[TBL] [Abstract][Full Text] [Related]
37. Pursuing for the better lung cancer therapy effect: Comparison of two different kinds of hyaluronic acid and nitroimidazole co-decorated nanomedicines.
Chen G; Zhang Y; Deng H; Tang Z; Mao J; Wang L
Biomed Pharmacother; 2020 May; 125():109988. PubMed ID: 32059173
[TBL] [Abstract][Full Text] [Related]
38. Preparation, characterization, and induction of cell apoptosis of cocoa procyanidins-gelatin-chitosan nanoparticles.
Zou T; Percival SS; Cheng Q; Li Z; Rowe CA; Gu L
Eur J Pharm Biopharm; 2012 Sep; 82(1):36-42. PubMed ID: 22641023
[TBL] [Abstract][Full Text] [Related]
39. Hyaluronidase Coated Molecular Envelope Technology Nanoparticles Enhance Drug Absorption via the Subcutaneous Route.
Soundararajan R; Wang G; Petkova A; Uchegbu IF; Schätzlein AG
Mol Pharm; 2020 Jul; 17(7):2599-2611. PubMed ID: 32379457
[TBL] [Abstract][Full Text] [Related]
40. In vitro effect of imatinib mesylate loaded on polybutylcyanoacrylate nanoparticles on leukemia cell line K562.
Hasandoost L; Akbarzadeh A; Attar H; Heydarinasab A
Artif Cells Nanomed Biotechnol; 2017 May; 45(3):665-669. PubMed ID: 27133178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
